Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.02 Billion USD | 4.9% |
| 2022 | 3.83 Billion USD | 0.39% |
| 2021 | 3.81 Billion USD | -13.29% |
| 2020 | 4.4 Billion USD | -0.43% |
| 2019 | 4.42 Billion USD | -6.53% |
| 2018 | 4.73 Billion USD | -3.92% |
| 2017 | 4.92 Billion USD | -0.61% |
| 2016 | 4.95 Billion USD | 24.91% |
| 2015 | 3.96 Billion USD | -9.27% |
| 2014 | 4.37 Billion USD | -13.5% |
| 2013 | 5.05 Billion USD | -8.16% |
| 2012 | 5.5 Billion USD | 9.78% |
| 2011 | 5.01 Billion USD | 29.64% |
| 2010 | 3.86 Billion USD | 16.03% |
| 2009 | 3.33 Billion USD | -1.88% |
| 2008 | 3.39 Billion USD | 39.18% |
| 2007 | 2.44 Billion USD | 29.86% |
| 2006 | 1.87 Billion USD | 68.64% |
| 2005 | 1.11 Billion USD | -13.38% |
| 2004 | 1.28 Billion USD | 28.04% |
| 2003 | 1 Billion USD | 28.61% |
| 2002 | 781.1 Million USD | 37.0% |
| 2001 | 570.14 Million USD | 13.24% |
| 2000 | 503.49 Million USD | 43.25% |
| 1999 | 351.47 Million USD | -0.49% |
| 1998 | 353.2 Million USD | 16.76% |
| 1997 | 302.5 Million USD | -7.94% |
| 1996 | 328.6 Million USD | 74.14% |
| 1995 | 188.7 Million USD | 21.66% |
| 1994 | 155.1 Million USD | 6.16% |
| 1993 | 146.1 Million USD | 32.22% |
| 1992 | 110.5 Million USD | 25.0% |
| 1991 | 88.4 Million USD | 12.04% |
| 1990 | 78.9 Million USD | 18.47% |
| 1989 | 66.6 Million USD | 25.9% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.94 Billion USD | -1.79% |
| 2024 Q2 | 3.92 Billion USD | -0.56% |
| 2023 Q1 | 4.11 Billion USD | 7.44% |
| 2023 Q3 | 4.05 Billion USD | -1.41% |
| 2023 Q2 | 4.1 Billion USD | -0.22% |
| 2023 Q4 | 4.02 Billion USD | -0.74% |
| 2023 FY | 4.02 Billion USD | 4.9% |
| 2022 Q4 | 3.83 Billion USD | -0.67% |
| 2022 Q1 | 4.01 Billion USD | 5.08% |
| 2022 Q2 | 4.04 Billion USD | 0.92% |
| 2022 FY | 3.83 Billion USD | 0.39% |
| 2022 Q3 | 3.85 Billion USD | -4.69% |
| 2021 Q2 | 4.36 Billion USD | -1.0% |
| 2021 Q1 | 4.4 Billion USD | 0.07% |
| 2021 Q4 | 3.81 Billion USD | -8.38% |
| 2021 Q3 | 4.16 Billion USD | -4.47% |
| 2021 FY | 3.81 Billion USD | -13.29% |
| 2020 Q2 | 4.36 Billion USD | 1.66% |
| 2020 Q3 | 4.51 Billion USD | 3.55% |
| 2020 Q1 | 4.29 Billion USD | -2.99% |
| 2020 Q4 | 4.4 Billion USD | -2.5% |
| 2020 FY | 4.4 Billion USD | -0.43% |
| 2019 Q4 | 4.42 Billion USD | -4.62% |
| 2019 Q2 | 4.85 Billion USD | 1.42% |
| 2019 FY | 4.42 Billion USD | -6.53% |
| 2019 Q1 | 4.78 Billion USD | 1.08% |
| 2019 Q3 | 4.63 Billion USD | -4.41% |
| 2018 Q2 | 4.97 Billion USD | -2.78% |
| 2018 Q1 | 5.11 Billion USD | 3.84% |
| 2018 FY | 4.73 Billion USD | -3.92% |
| 2018 Q4 | 4.73 Billion USD | -2.77% |
| 2018 Q3 | 4.86 Billion USD | -2.11% |
| 2017 Q1 | 4.99 Billion USD | 0.91% |
| 2017 Q3 | 5.06 Billion USD | -1.4% |
| 2017 FY | 4.92 Billion USD | -0.61% |
| 2017 Q2 | 5.13 Billion USD | 2.66% |
| 2017 Q4 | 4.92 Billion USD | -2.69% |
| 2016 Q1 | 3.96 Billion USD | -0.08% |
| 2016 FY | 4.95 Billion USD | 24.91% |
| 2016 Q3 | 5.34 Billion USD | 36.42% |
| 2016 Q4 | 4.95 Billion USD | -7.38% |
| 2016 Q2 | 3.92 Billion USD | -1.06% |
| 2015 Q3 | 4.09 Billion USD | -3.17% |
| 2015 FY | 3.96 Billion USD | -9.27% |
| 2015 Q2 | 4.22 Billion USD | 1.25% |
| 2015 Q1 | 4.17 Billion USD | -4.51% |
| 2015 Q4 | 3.96 Billion USD | -3.08% |
| 2014 Q2 | 4.94 Billion USD | -0.72% |
| 2014 Q1 | 4.97 Billion USD | -1.52% |
| 2014 Q4 | 4.37 Billion USD | -4.79% |
| 2014 FY | 4.37 Billion USD | -13.5% |
| 2014 Q3 | 4.59 Billion USD | -7.06% |
| 2013 Q1 | 5.38 Billion USD | -2.13% |
| 2013 Q2 | 5.32 Billion USD | -1.1% |
| 2013 FY | 5.05 Billion USD | -8.16% |
| 2013 Q4 | 5.05 Billion USD | -3.64% |
| 2013 Q3 | 5.24 Billion USD | -1.54% |
| 2012 FY | 5.5 Billion USD | 9.78% |
| 2012 Q1 | 5.33 Billion USD | 6.38% |
| 2012 Q4 | 5.5 Billion USD | 0.75% |
| 2012 Q2 | 5.29 Billion USD | -0.73% |
| 2012 Q3 | 5.46 Billion USD | 3.17% |
| 2011 Q2 | 4.45 Billion USD | 5.51% |
| 2011 Q1 | 4.22 Billion USD | 9.29% |
| 2011 Q4 | 5.01 Billion USD | 7.32% |
| 2011 Q3 | 4.67 Billion USD | 4.76% |
| 2011 FY | 5.01 Billion USD | 29.64% |
| 2010 Q1 | 3.24 Billion USD | -2.64% |
| 2010 Q4 | 3.86 Billion USD | 0.1% |
| 2010 Q3 | 3.86 Billion USD | 25.47% |
| 2010 Q2 | 3.07 Billion USD | -5.12% |
| 2010 FY | 3.86 Billion USD | 16.03% |
| 2009 FY | 3.33 Billion USD | -1.88% |
| 2009 Q2 | 3.49 Billion USD | 8.88% |
| 2009 Q3 | 3.44 Billion USD | -1.34% |
| 2009 Q4 | 3.33 Billion USD | -3.39% |
| 2009 Q1 | 3.21 Billion USD | -5.45% |
| 2008 Q2 | 2.9 Billion USD | 9.95% |
| 2008 Q1 | 2.64 Billion USD | 8.36% |
| 2008 FY | 3.39 Billion USD | 39.18% |
| 2008 Q3 | 2.87 Billion USD | -1.2% |
| 2008 Q4 | 3.39 Billion USD | 18.25% |
| 2007 Q1 | 2.08 Billion USD | 10.91% |
| 2007 Q2 | 2.14 Billion USD | 3.02% |
| 2007 Q3 | 2.29 Billion USD | 7.03% |
| 2007 Q4 | 2.44 Billion USD | 6.18% |
| 2007 FY | 2.44 Billion USD | 29.86% |
| 2006 FY | 1.87 Billion USD | 68.64% |
| 2006 Q3 | 1.86 Billion USD | 5.39% |
| 2006 Q4 | 1.87 Billion USD | 0.61% |
| 2006 Q1 | 1.68 Billion USD | 51.62% |
| 2006 Q2 | 1.77 Billion USD | 4.9% |
| 2005 Q2 | 1.16 Billion USD | -3.37% |
| 2005 Q1 | 1.21 Billion USD | -5.92% |
| 2005 FY | 1.11 Billion USD | -13.38% |
| 2005 Q4 | 1.11 Billion USD | -2.63% |
| 2005 Q3 | 1.14 Billion USD | -2.14% |
| 2004 Q4 | 1.28 Billion USD | 2.96% |
| 2004 Q3 | 1.24 Billion USD | -2.73% |
| 2004 Q2 | 1.28 Billion USD | 1.56% |
| 2004 Q1 | 1.26 Billion USD | 25.89% |
| 2004 FY | 1.28 Billion USD | 28.04% |
| 2003 Q4 | 1 Billion USD | 5.94% |
| 2003 Q3 | 948.3 Million USD | 5.58% |
| 2003 Q2 | 898.2 Million USD | 7.87% |
| 2003 Q1 | 832.7 Million USD | 6.61% |
| 2003 FY | 1 Billion USD | 28.61% |
| 2002 Q3 | 751.8 Million USD | 8.14% |
| 2002 Q2 | 695.2 Million USD | 15.67% |
| 2002 Q1 | 601 Million USD | 5.41% |
| 2002 FY | 781.1 Million USD | 37.0% |
| 2002 Q4 | 781.1 Million USD | 3.9% |
| 2001 Q4 | 570.14 Million USD | 6.21% |
| 2001 FY | 570.14 Million USD | 13.24% |
| 2001 Q1 | 495.79 Million USD | -1.53% |
| 2001 Q2 | 508.31 Million USD | 2.52% |
| 2001 Q3 | 536.8 Million USD | 5.6% |
| 2000 Q1 | 368.36 Million USD | 4.8% |
| 2000 FY | 503.49 Million USD | 43.25% |
| 2000 Q2 | 508.28 Million USD | 37.98% |
| 2000 Q4 | 503.49 Million USD | 0.0% |
| 2000 Q3 | - USD | -100.0% |
| 1999 Q2 | 371.6 Million USD | 6.11% |
| 1999 Q3 | 382.3 Million USD | 2.88% |
| 1999 Q4 | 351.47 Million USD | -8.06% |
| 1999 FY | 351.47 Million USD | -0.49% |
| 1999 Q1 | 350.2 Million USD | -0.85% |
| 1998 Q3 | 343.5 Million USD | 16.17% |
| 1998 Q2 | 295.7 Million USD | -1.7% |
| 1998 Q1 | 300.8 Million USD | -0.56% |
| 1998 Q4 | 353.2 Million USD | 2.82% |
| 1998 FY | 353.2 Million USD | 16.76% |
| 1997 Q4 | 302.5 Million USD | 0.0% |
| 1997 FY | 302.5 Million USD | -7.94% |
| 1996 Q4 | 328.6 Million USD | 0.0% |
| 1996 FY | 328.6 Million USD | 74.14% |
| 1995 FY | 188.7 Million USD | 21.66% |
| 1995 Q4 | 188.7 Million USD | 0.0% |
| 1994 FY | 155.1 Million USD | 6.16% |
| 1994 Q4 | 155.1 Million USD | 0.0% |
| 1993 FY | 146.1 Million USD | 32.22% |
| 1993 Q4 | 146.1 Million USD | 0.0% |
| 1992 Q4 | 110.5 Million USD | 0.0% |
| 1992 FY | 110.5 Million USD | 25.0% |
| 1991 FY | 88.4 Million USD | 12.04% |
| 1991 Q4 | 88.4 Million USD | 0.0% |
| 1990 Q4 | 78.9 Million USD | 0.0% |
| 1990 FY | 78.9 Million USD | 18.47% |
| 1989 FY | 66.6 Million USD | 25.9% |
| 1989 Q4 | 66.6 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 581.38 Million USD | -591.626% |
| Bausch Health Companies Inc. | 1.54 Billion USD | -160.427% |
| Catalent, Inc. | 574 Million USD | -600.523% |
| Emergent BioSolutions Inc. | 328.9 Million USD | -1122.56% |
| Elanco Animal Health Incorporated | 1.73 Billion USD | -131.758% |
| Perrigo Company plc | 1.14 Billion USD | -252.441% |
| Zoetis Inc. | 2.56 Billion USD | -56.825% |